Similar articles

• Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver.

  Sohlenius AK, Eriksson AM, Högström C, Kimland M, DePierre JW. Sohlenius AK, et al. Pharmacol Toxicol. 1993 Feb;72(2):90-3. doi: 10.1111/j.1600-0773.1993.tb00296.x. Pharmacol Toxicol. 1993. PMID: 8386358
• Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes.

  Orellana A, Holuigue L, Hidalgo PC, Faúndez V, González A, Bronfman M. Orellana A, et al. Eur J Biochem. 1993 Aug 1;215(3):903-6. doi: 10.1111/j.1432-1033.1993.tb18108.x. Eur J Biochem. 1993. PMID: 8354295
• Lipid-metabolizing enzymes, CoASH and long-chain acyl-CoA in rat liver after treatment with tiadenol, nicotinic acid and niadenate.

  Bakke OM, Berge RK. Bakke OM, et al. Biochem Pharmacol. 1982 Dec 1;31(23):3930-3. doi: 10.1016/0006-2952(82)90313-6. Biochem Pharmacol. 1982. PMID: 7159471 No abstract available.
• Receptor-mediated mechanisms of peroxisome proliferators.

  Green S. Green S. Biochem Pharmacol. 1992 Feb 4;43(3):393-401. doi: 10.1016/0006-2952(92)90554-v. Biochem Pharmacol. 1992. PMID: 1311577 Review. No abstract available.
• Hepatocarcinogenesis of peroxisome proliferators.

  Rao MS, Reddy JK. Rao MS, et al. Ann N Y Acad Sci. 1996 Dec 27;804:573-87. doi: 10.1111/j.1749-6632.1996.tb18646.x. Ann N Y Acad Sci. 1996. PMID: 8993574 Review. No abstract available.